Engineered 3D hydrogels with full-length fibronectin that sequester and present growth factors

Area of Science:

• Biomaterials Science
• Tissue Engineering
• Cell Biology

Background:

• Extracellular matrix (ECM)-derived matrices like Matrigel support cell functions but have undefined composition and variability.
• There is a need for rationally designed biomaterials that mimic ECM roles with controlled properties.

Purpose of the Study:

• To develop fibronectin (FN)-based 3D hydrogels with tunable stiffness and degradability.
• To enable controlled, solid-phase presentation of growth factors for physiological mimicry.
• To investigate the efficacy of these hydrogels in enhancing angiogenesis and bone regeneration.

Main Methods:

• Fabrication of fibronectin-based 3D hydrogels with controlled mechanical properties and degradation rates.
• Incorporation of full-length fibronectin for physiological growth factor presentation.
• In vitro and in vivo studies incorporating vascular endothelial growth factor (VEGF) and bone morphogenetic protein 2 (BMP2).

Main Results:

• Demonstrated successful development of well-defined, reproducible synthetic microenvironments.
• Showcased enhanced angiogenesis in vitro and in vivo upon VEGF incorporation.
• Confirmed enhanced bone regeneration in vivo upon BMP2 incorporation.

Conclusions:

• Fibronectin-based hydrogels offer a significant advancement over ECM-derived matrices for 3D cell culture.
• These biomaterials provide a controlled and reproducible platform for growth factor delivery.
• The developed hydrogels show promise for applications in tissue regeneration and regenerative medicine.